Brain imaging comparison of cancer medications
26 October 2018
The trial investigates the effect on the brain blood flow of a single dose of two prostate cancer medications (which will be taken during separate visits) at King's College Hospital, London. The study involves a medical screening followed by 3 full-day visits separated by about 6 weeks. During the full-day visits you will take a single dose of the study medication (or placebo) orally, and have an MRI scan. Transport will be provided, and you will be reimbursed for your time (up to £830).
Keywords
Ethical approval
study ref: 18/SC/0433, approved by South Central - Berkshire Research Ethics Committee. This study is sponsored by Bayer Consumer Care AG, EurdraCT No: 2018-001599-39 .
